Hawaii Legislature (healthcare bills) · December 8, 2025 · Primary source
HI HB 1112: RELATING TO VIRAL HEPATITIS.
Summary
Hawaii HB 1112 establishes a Hepatitis Prevention Program within the state Department of Health and appropriates funds for hepatitis B and C prevention, screening, and treatment support. The bill also repeals an outdated statutory reference to hepatitis and blood transfusions. It carries a nominal effective date of 7/1/3000 and has been carried over to the 2026 Regular Session without enactment.
What this may mean
If enacted, the bill creates a state-funded hepatitis prevention infrastructure within the DOH, with implications for providers delivering hepatitis screening and treatment in Hawaii. The measure has no direct effect on federal regulatory compliance, billing rules, or enforcement exposure. It remains pending with no operative effect.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- Hawaii Legislature (healthcare bills) · September 13, 2026HI SB 956: RELATING TO PRESCRIPTION DRUGS.Score 60
- Hawaii Legislature (healthcare bills) · July 17, 2026HI SB 847: RELATING TO PSYCHOLOGISTS.Score 60
- Hawaii Legislature (healthcare bills) · September 13, 2026HI HB 1092: RELATING TO MEDICAID THIRD PARTY LIABILITY.Score 46
- Hawaii Legislature (healthcare bills) · July 15, 2026HI SB 2998: RELATING TO MEDICAL CANNABIS.Score 46
- Hawaii Legislature (healthcare bills) · September 13, 2026HI SB 824: RELATING TO PEER SUPPORT PROGRAMS.Score 38
- Hawaii Legislature (healthcare bills) · July 15, 2026HI SB 2788: RELATING TO ARTIFICIAL INTELLIGENCE FOR THE PROTECTION OF MINORS.Score 28